{"title":"Reduced locomotor activity of rats mediated by peripheral beta adrenergic receptors.","authors":"J M O'Donnell","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The nonselective beta adrenergic agonist isoproterenol, the beta-2 selective agonist clenbuterol and, to a lesser extent, the beta-1 selective agonists dobutamine and prenalterol reduced locomotor activity of rats in a dose-dependent manner. These effects were antagonized by the beta adrenergic antagonist propranolol, suggesting mediation by beta adrenergic receptors. The hydrophilic beta adrenergic antagonist CGP-12177, which crosses the blood-brain barrier poorly, also blocked the effect of clenbuterol on locomotor activity with a potency similar to propranolol, suggesting that stimulation of peripheral beta adrenergic receptors is sufficient for reducing locomotor activity.</p>","PeriodicalId":21140,"journal":{"name":"Research communications in chemical pathology and pharmacology","volume":"82 3","pages":"375-8"},"PeriodicalIF":0.0000,"publicationDate":"1993-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research communications in chemical pathology and pharmacology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The nonselective beta adrenergic agonist isoproterenol, the beta-2 selective agonist clenbuterol and, to a lesser extent, the beta-1 selective agonists dobutamine and prenalterol reduced locomotor activity of rats in a dose-dependent manner. These effects were antagonized by the beta adrenergic antagonist propranolol, suggesting mediation by beta adrenergic receptors. The hydrophilic beta adrenergic antagonist CGP-12177, which crosses the blood-brain barrier poorly, also blocked the effect of clenbuterol on locomotor activity with a potency similar to propranolol, suggesting that stimulation of peripheral beta adrenergic receptors is sufficient for reducing locomotor activity.